#United States #Virginia Beach #LifeNet Health #OraGen® #Bone Allograft

Introducing OraGen®: A Breakthrough in Dental Surgery

LifeNet Health has unveiled OraGen®, marking a significant advancement in dental bone grafting solutions. As the first and only viable bone allograft, OraGen® combines cryopreserved corticocancellous bone with a unique blend of endogenous lineage-committed bone cells and demineralized bone matrix. This exceptional composition offers a trifecta of benefits crucial for bone regeneration: osteogenicity, osteoconductivity, and osteoinduction.

Key Features of OraGen®

1. Osteogenicity: The fully viable allograft contains bone cells capable of producing new bone, essential for successful grafting.
2. Osteoconductivity: The graft provides a robust scaffold that facilitates cell attachment and growth, enhancing the potential for successful integration into existing bone structures.
3. Osteoinduction: Retained natural growth factors stimulate the body's healing processes, promoting enhanced bone repair and regeneration.

Applications in Dentistry

OraGen® is particularly designed for various dental procedures. It is ideal for:

• - Sinus augmentation
• - Ridge augmentation
• - Repairing large defects in the mandible or maxilla.

The incorporation of OraGen® is expected to transform standards in dental tissue engineering, set against the backdrop of LifeNet Health's successful history with advanced cellular allografts for bone repair and reconstruction. The innovative properties of this allograft allow for rapid new bone formation immediately post-implantation, sustaining growth long term.

Unmatched Safety and Convenience

Safety and user-friendliness are paramount in healthcare. OraGen® undergoes meticulous aseptic processing, featuring a proprietary cryopreservation technique that maximizes cell viability. This process ensures that grafts are processed within 72 hours, which is notably 24 hours faster than that of rival products. Additionally, its thawing time is crucified to under five minutes, making preparation in clinical environments swift and seamless.

OraGen® is now available throughout the United States via LifeNet Health’s strategic partner, Salvin Dental Specialties, well-known for their expertise in dental surgical solutions.

Industry Impact

LifeNet Health's Chief Growth Officer, Daniel Osborne, expressed enthusiasm about the collaboration with Salvin Dental Specialties, emphasizing the commitment to provide state-of-the-art solutions that enhance patient outcomes and push forward the field of regenerative medicine. Ken Serota, CEO of Young Innovations, echoed this sentiment, remarking that their exclusive distribution agreement for OraGen® is a testament to the dedication towards offering advanced regenerative solutions to customers.

This partnership is poised to empower dental surgeons with tools that significantly improve patients' quality of life.

LifeNet Health's Legacy

As a global leader in regenerative medicine, LifeNet Health is dedicated to innovating medical capabilities, from organ donation to bio-implants. Their mission centers around enhancing human life quality through groundbreaking advancements in transplantation and research. With the introduction of OraGen®, they continue their legacy of excellence, providing professionals in the dental field with transformative solutions for bone regeneration.

In conclusion, OraGen® is more than just a product; it represents a monumental advancement in dental surgery, offering new possibilities for patients and practitioners alike. As healthcare continues to evolve, innovations like OraGen® will be at the forefront, redefining what is achievable in bone grafting and regeneration.